Subclinical atherosclerosis in Behcet's disease and its inverse relation to azathioprine use: an updated meta-analysis.
Atherosclerosis
Azathioprine
Behcet’s disease
Intima media thickness
Journal
Clinical and experimental medicine
ISSN: 1591-9528
Titre abrégé: Clin Exp Med
Pays: Italy
ID NLM: 100973405
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
20
03
2023
accepted:
26
04
2023
medline:
2
11
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
To evaluate the intima media thickness of carotid arteries (IMT) and its clinical, laboratory and treatment correlates in Behcet's disease (BD). Systematic search of EMBASE and PubMed databases from January 2016 to October 2022; we employed random effect meta-analyses for continuous outcomes and Peto's odds ratio for rare events. The meta-analysis included 36 case control studies: the IMT was greater in BD (n = 1103) than in controls (n = 832) (p < 0.0001) with wide heterogeneity (I
Identifiants
pubmed: 37169964
doi: 10.1007/s10238-023-01084-3
pii: 10.1007/s10238-023-01084-3
doi:
Substances chimiques
Azathioprine
MRK240IY2L
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3431-3442Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Bettiol A, Alibaz-Oner F, Direskeneli H, et al. Vascular Behçet syndrome: from pathogenesis to treatment. Nat Rev Rheumatol. 2023;19:111–26.
pubmed: 36544027
Seyahi E. Behçet’s disease: how to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol. 2016;30:279–95.
pubmed: 27886800
Merashli M, Ster IC, Ames PRJ. Subclinical atherosclerosis in Behcet’s disease: a systematic review and meta-analysis. Semin Arthritis Rheum. 2016;45:502–10.
pubmed: 26239908
Upala S, Yong WC, Sanguankeo A. Increased arterial stiffness in Behçet’s disease: a systematic review and meta-analysis. Korean Circ J. 2017;47:477–82.
pubmed: 28765739
pmcid: 5537149
Rethlefsen ML, Kirtley S, Waffenschmidt S, PRISMA-S Group, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10:39.
pubmed: 33499930
pmcid: 7839230
Wells GA, Shea B, O’Connell D et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: URL: www.ohri.ca/programs/clinical_epidemiology/oxford.htm .
Borenstein M, Hedges LV, Higgins JP, Rothstein HA. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.
pubmed: 26061376
Brockhaus AC, Grouven U, Bender R. Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events. Biom J. 2016;58:1428–44.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–60.
Tang JL, Liu JL. Misleading funnel plot for the detection of bias in meta-analysis. Clin Epidemiol. 2000;253:477–84.
Lau J, Ioannidis JPA, Terrin N, et al. The case of the misleading funnel plot. Br Med J. 2006;333:597–600.
Sait A, Ulgen MS, Akdeniz S, et al. Intima-media thickness and arterial distensibility in Behçet’s disease. Angiology. 2004;55:413–9.
Keser G, Aksu K, Tamsel S, et al. Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet’s disease. Clin Exp Rheumatol. 2005;23(4 Suppl. 38):S71–6.
pubmed: 16273769
Oflaz H, Mercanoglu F, Karaman O, et al. Impaired endothelium-dependent flow-mediated dilation in Behçet’s disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract. 2005;59:777.
pubmed: 15963203
Oztürk MA, Oktar SO, Unverdi S, et al. Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet’s disease. Rheumatol Int. 2006;26:867–72.
pubmed: 16402216
Rhee MY, Chang HK, Kim SK. Intima-media thickness and arterial stiffness of carotid artery in Korean patients with Behçet’s disease. J Korean Med Sci. 2007;22:387–92.
pubmed: 17596642
pmcid: 2693626
Caliskan M, Gullu H, Yilmaz S, et al. Cardiovascular prognostic value of vascular involvement in Behcet’s disease. Int J Cardiol. 2008;125:428–30.
pubmed: 17408778
Hong SN, Park JC, Yoon NS, et al. Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement. Korean J Intern Med. 2008;23:87–9.
pubmed: 18646511
pmcid: 2686971
Oztürk MA, Unverdi S, Oktar SO, et al. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease. Clin Rheumatol. 2008;27:961–6.
pubmed: 18204875
Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Behçet’s syndrome. Semin Arthritis Rheum. 2008;38:1–12.
pubmed: 18221989
Ozgen M, Koca SS, Dagli N, et al. Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res. 2010;41:457–63.
pubmed: 21044750
Messedi M, Frigui M, Ben Mahfoudh K, et al. Intima-media thickness of carotid artery in patients with Behçet’s disease. Arch Med Res. 2011;42:398–404.
pubmed: 21854817
Can M, Gunes M, Haliloglu OA, et al. Effect of vitamin D deficiency and replacement on endothelial functions in Behçet’s disease. Clin Exp Rheumatol. 2012;30(3 Suppl. 72):S57-61.
pubmed: 23020973
Hassan S, Gheita T, Ghoneim S, Nasr L. Subclinical atherosclerosis in Behçet’s disease. Turk J Rheumatol. 2012;27:109–14.
Yurdakul S, Erdemir VA, Yıldırımtürk O, Gürel MS, Aytekin S. Evaluation of endothelial functions in patients with Behcet’s disease without overt vascular involvement. Turk Kardiyol Dern Ars. 2012;40:518–22.
pubmed: 23363898
Caldas CA, Borba EF, Bortolotto LA, et al. Increased arterial stiffness assessed by pulse wave velocity in Behçet’s disease and its association with the lipid profile. J Eur Acad Dermatol Venereol. 2013;27:454–9.
pubmed: 22329367
Uyar B, Solak A, Genç B, et al. Evaluation of arterial stiffness in patients with Behçet’s disease by using noninvasive radiological methods such as intima-media thickness of the carotid, ankle-brachial pressure index, coronary artery calcium scoring, and their relation to serum fetuin-A levels: a case-control study. Ann Dermatol. 2015;27:702–8.
pubmed: 26719639
pmcid: 4695422
Icli A, Cure E, Cumhur Cure M, et al. Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet’s disease. J Investig Med. 2016;64:875–81.
pubmed: 26941246
pmcid: 4819671
Sereflican B, Kizildag B, Halicioglu S, et al. Extra-medial thickness of carotid artery in patients with Behçet’s disease: evaluation of atherosclerotic vessel wall changes with a novel carotid artery ultrasound index. Int J Dermatol. 2016;55:1124–30.
pubmed: 27228961
Yıldırım A, Karakaş MS, Kılınç AY, Altekin RE, Yalçınkaya AS. Evaluation of arterial stiffness and subclinical atherosclerosis in patients with Behçet’s disease without cardiovascular involvement. Turk Kardiyol Dern Ars. 2016;44:575–81.
pubmed: 27774966
Cure E, Icli A, Ugur Uslu A, et al. Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z Rheumatol. 2017;76:259–66.
pubmed: 27431747
El-Gazzar I, El-Dakrony AH, Sayed S, et al. Clinical significance of metabolic syndrome and carotid intima-media thickness in Behҫet’s disease patients: relation to disease activity. Egypt Rheumatol. 2017;39:171–4.
Yolbaş S, Gözel N, Dağlı MN, Koca SS, Dönder E. Carotid artery stiffness in Behçet’s disease. Eur J Rheumatol. 2017;4:122–6.
pubmed: 28638685
pmcid: 5473447
Alis D, Durmaz ESM, Civcik C, et al. Assessment of the common carotid artery wall stiffness by shear wave elastography in Behcet’s disease. Med Ultrason. 2018;20:446–52.
pubmed: 30534651
Elden MS, Hmmad G, Farouk H, Fawzy RM, Abdelwhaba B. Neutrophil-to-lymphocyte ratio: relation to disease activity and carotid intima-media thickness in Behçet’s disease. Egypt Rheumatol Rehabil. 2018;45:133–9.
Icli A, Cure MC, Cure E, et al. Soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (Tweak) independently predicts subclinical atherosclerosis in Behcet’s disease. Acta Med. 2018;61:86–92.
Kankilic N, Aslan A, Karahan O, et al. Investigation of the arterial intima-media thickness in Behcet’s disease patients without vascular complaints. Vascular. 2018;26:356–61.
pubmed: 29182089
Ozdemir R, Yagmur J, Acikgoz N, et al. Relationship between serum homocysteine levels and structural-functional carotid arterial abnormalities in inactive Behçet’s disease. Kardiol Pol. 2018;76:413–7.
pubmed: 29192953
Ozisler C, Kaplanoglu H. Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with Behçet’s disease. Int J Rheum Dis. 2019;22:781–8.
pubmed: 30985087
Hassan WA, Behiry EG, Abdelshafy S, Salem T, Baraka EA. Assessment of endocan serum level in patients with Behçet disease: relation to disease activity and carotid intima media thickness. Egypt J Immunol. 2020;27:129–39.
pubmed: 33180395
El-Najjar AR, Alsammak AA. Association between serum homocysteine and arterial stiffness in patients with Behçet’s disease. Egypt Rheumatol. 2020;42:129–33.
Kaymaz S, Yılmaz H, Ufuk F, et al. Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet’s disease with symptoms or signs of vascular involvement: a cross-sectional study. Arch Rheumatol. 2021;36:258–66.
pubmed: 34527931
pmcid: 8418758
Uslu Yurteri E, Üstüner E, Torgutalp M, et al. Can subclinical atherosclerosis be assessed more precisely in Behçet syndrome patients by using a particular cutoff value for carotid intima media thickness? J Clin Rheumatol. 2021;28:e73–6.
Rodrigues FM, Bacchiega AB, Bacchiega BC, et al. Evaluation of endothelial function in patients with Behçet’s disease in remission: a cross-sectional study. Eur J Rheumatol. 2022;9:139–43.
pubmed: 35156628
Hussein MA, Ramadan MM, Moneam MAE, Halim HAE, Ghaffar NAE, Fawzy MW. Interleukin 37; a possible marker of arterial stiffness in Behçet’s disease. Am J Med Sc. 2022;364:425–32.
Aydogan Baykara R, Yilmaz PD, Göktepe MH, Kadiyoran C, Ogul M, Kucuk A, et al. Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease. Clin Exp Hypertens. 2022;44:480–6.
pubmed: 35502687
Ismail MA, Mounir O, Sedky A, Algahlan HA, Abda EA, Radwan AR, et al. Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis? Clin Rheumatol. 2022. https://doi.org/10.1007/s10067-022-06368-9 .
doi: 10.1007/s10067-022-06368-9
pubmed: 36112245
pmcid: 9823020
Bhakta BB, Brennan P, James TE, et al. Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38:728–33.
pubmed: 10501420
Forbees C, Swearingen C, Yazici Y. Behcet’s syndrome activity score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with the Behcet’s disease current activity form (BDCAF). Arthritis Rheum. 2008;58(Suppl 9):S854–5.
Chang HK, Cheon KS. The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci. 2002;17:371–4.
pubmed: 12068142
pmcid: 3054891
Krause I, Molad Y, Mitrani M, Weinberger A. Pathergy reaction in Behcet’s disease: lack of correlation with mucocutaneous manifestations and systemic disease expression. Clin Exp Rheumatol. 2000;18:71–4.
pubmed: 10728447
Suvila K, Langén V, Cheng S, Niiranen TJ. Age of hypertension onset: overview of research and how to apply in practice. Curr Hypertens Rep. 2020;22:68.
pubmed: 32852608
pmcid: 7452883
Sharifi M, Futema M, Nair D, Humphries SE. Polygenic hypercholesterolemia and cardiovascular disease risk. Curr Cardiol Rep. 2019;21:43.
pubmed: 31011892
pmcid: 6477004
Toledo-Samaniego N, Oblitas CM, Peñaloza-Martínez E, et al. Arterial and venous involvement in Behçet’s syndrome: a narrative review. J Thromb Thrombolysis. 2022;54:162–71.
pubmed: 35182310
Desbois AC, Wechsler B, Resche-Rigon M, et al. Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease. Arthritis Rheum. 2012;64:2753–60.
pubmed: 22354392
Saadoun D, Asli B, Wechsler B, et al. Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine. 2012;91:18–24.
pubmed: 22198498
Torgutalp M, Sahin Eroglu D, Sezer S, Yayla ME, Karatas G, Uslu Yurteri E, et al. Analysis of vascular involvement in 460 patients with Behçet’s syndrome: clinical characteristics and associated factors. Joint Bone Spine. 2022;89:105277.
pubmed: 34536626
Gasbarrino K, Di Iorio D, Daskalopoulou SS. Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease. Eur Heart J. 2022;43:460–73.
pubmed: 34849703
Savey L, Resche-Rigon M, Wechsler B, et al. Ethnicity and association with disease manifestations and mortality in Behçet’s disease. Orphanet J Rare Dis. 2014;9:42.
pubmed: 24674137
pmcid: 3986678
Rozenbaum M, Boulman N, Slobodin G, et al. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity. J Clin Rheumatol. 2007;13:124–7.
pubmed: 17551376
Seyahi E. Phenotypes in Behçet’s syndrome. Intern Emerg Med. 2019;14:677–89.
pubmed: 30747365
Tada H, Takamura M, Kawashiri MA. What is the mechanism of genetic contributions to the development of atherosclerosis? Atherosclerosis. 2020;307:72–4.
pubmed: 32451078
Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348:1435–41.
pubmed: 12686699
Jezovnik MK, Fareed J, Poredos P. Subjects with a history of idiopathic deep venous thrombosis have long-term increased levels of inflammatory markers and markers of endothelial damage. Clin Appl Thromb Hemost. 2017;23:124–31.
pubmed: 27663463
Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.
pubmed: 20031199
Migdalski A, Jawien A. New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: a narrative review. Ann Transl Med. 2021;9:1207.
pubmed: 34430648
pmcid: 8350668
Merashli M, Bucci T, Pastori D, et al. Plasma homocysteine in Behcet’s disease: a systematic review and meta-analysis. Thromb Haemost. 2022. https://doi.org/10.1055/s-0041-1740637 .
doi: 10.1055/s-0041-1740637
pubmed: 35052008
Wu X, Wang Z, Shi J, Yu X, Li C, Liu J, Zhang F, Chen H, Zheng W. Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet’s disease. Arthritis Res Ther. 2022;24:249.
pmcid: 9635113
Susser LI, Rayner KJ. Through the layers: how macrophages drive atherosclerosis across the vessel wall. J Clin Invest. 2022;132:e157011.
pubmed: 35499077
pmcid: 9057606
Pols TW, Bonta PI, Pires NM, Otermin I, Vos M, de Vries MR, et al. 6-mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages. Arterioscler Thromb Vasc Biol. 2010;30:1591–7.
pubmed: 20413732
Casula M, Andreis A, Avondo S, Vaira MP, Imazio M. Colchicine for cardiovascular medicine: a systematic review and meta-analysis. Future Cardiol. 2022;18:647–59.
pubmed: 35787150
Thomas T, Chandan JS, Subramanian A, et al. Epidemiology, morbidity and mortality in Behçet’s disease: a cohort study using the health improvement network (THIN). Rheumatology. 2020;59:2785–95.
pubmed: 32040196
Emmi G, Becatti M, Bettiol A, et al. Behçet’s syndrome as a model of thrombo-inflammation: the role of neutrophils. Front Immunol. 2019;10:1085.
pubmed: 31139195
pmcid: 6527740
Kim EH, Park MJ, Park S, et al. Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease. J Inflamm. 2015;12:41.
Emmi G, Bagni G, Lastraioli E, Di Patti F, Bettiol A, Fiorillo C, Becatti M, Silvestri E, Urban ML, Emmi L, Prisco D, Arcangeli A. A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome. Ann Rheum Dis. 2022;81:386–97.
pubmed: 34844932
Chekaoui A, Lahmar K, Belguendouz H, et al. Increased IL-1β levels are associated with an imbalance of “oxidant/antioxidant” status during Behçet’s disease. Eur Cytokine Netw. 2018;29:95–102.
pubmed: 30547891